Periscope Capital’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Periscope Capital’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-241,900	Closed	-$72.6K	–	514
2023 Q4	$72.6K	Hold	241,900	–	–	0.01%	225
2023 Q3	$84.4K	Hold	241,900	–	–	0.01%	319
2023 Q2	$40.9K	Hold	241,900	–	–	﹤0.01%	457
2023 Q1	$35.1K	Hold	241,900	–	–	﹤0.01%	585
2022 Q4	$14.3K	Hold	241,900	–	–	﹤0.01%	731
2022 Q3	$9K	Hold	241,900	–	–	﹤0.01%	1015
2022 Q2	$27K	Hold	241,900	–	–	﹤0.01%	844
2022 Q1	$43K	Hold	241,900	–	–	﹤0.01%	991
2021 Q4	$78K	Buy	+241,900	New	+$76.5K	﹤0.01%	873

Periscope Capital's DMAQR Position: Q1 2024 in Review

Periscope Capital sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 241,900 shares — an estimated $72.6K sold.

Periscope Capital first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $84.4K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Periscope Capital reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Periscope Capital sold 241,900 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $72.6K.
Periscope Capital first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Periscope Capital's Deep Medicine Acquisition Corp. Rights position peaked at $84.4K in Q3 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Periscope Capital's 13F filing for Q1 2024, filed 13 May 2024.